Search

Kyle Butler

February 3, 2024 by ha8m@virginia.edu

Office Location: Pinn 4219

Email: hhm7yn@virginia.edu

A mechanistic understanding of diseases is crucial for the development of diagnostic tests and treatment plans. Through the generation of molecular biosensors, we can gain a better understanding of how diseases can be detected and diagnosed at much earlier stages. My goal is to develop molecular biosensors to aid in the creation of easy-to-use diagnostic tests. Outside of my passion for science, I also enjoy playing basketball, going on hikes, and water-related activities.

Current position:

Laboratory Specialist, Department of Molecular Physiology and Biophysics    02/2024-present

Previous Education and Professional Experiences:

Research Assistant I    09/2022-01/2024
MD Anderson, Department of Cancer Biology, Houston, TX

M.S. in Biotechnology, Georgetown University   08/2021-05-2022

B.S. in Physics, Gonzaga University        08/2017-05/2021

Presentations:

1.     Mittal SK, Hartley C, Hagen C, Butler K, Roberts M, Abdo J, Ajay Bansal MD. “Multi-Institutional Study Assessing STLA101 Assay Performance for the Detection of Cancerous Progression in Barrett’s Esophagus”. Presented at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting. Denver, CO. March 16th, 2022.

2.     Hartley C, Bansal A, Hagen C, Butler K, Roberts M, Abdo J, Mittal SK. “Mass spectrometry detects lower frequency of routine markers and consistent overexpression of novel disease drivers in Barrett’s-related esophageal cancer”. Presented at The American Association of Cancer Research Annual Meeting. New Orleans, LA. April 10th, 2022.

3.     Patil AP, Bansal A, Mittal SK, Abdo J, Butler K, Roberts M, Catherine Hagen C, Hartley C. “Markers in STLA101 Assay detect differential expression in intramucosal vs. invasive Esophageal Adenocarcinoma”. Presented at Digestive Disease Week. San Diego, CA. May 22nd, 2022.